Skip to main content
NVDA-0.30%AAPL+1.26%GOOGL+1.34%MSFT+2.65%AMZN-2.09%TSM+0.60%SPCX-2.25%AVGO+2.77%TSLA+0.18%META+1.30%LLY+0.54%SKHY+13.30%BRK-B-0.49%MU-1.89%WMT-0.46%AMD+3.24%JPM+1.05%XOM+1.17%V-0.31%JNJ+0.86%ASMLa+0.04%MA+0.08%ABBV-0.01%INTC+1.91%1398.HK+2.23%CVX+0.46%0700.HK-2.58%ORCL+10.58%COST-0.95%CSCO-0.98%KO+0.60%1816.HK+7.22%PG-0.61%UNH-0.80%BAC+0.34%3988.HK+1.66%AMAT+5.07%CAT+0.01%AP2d-0.42%0857.HK+2.91%LRCX+5.39%HD-0.30%PM+0.01%DELL-1.64%0939.HK+2.12%GE+1.17%1288.HK+1.48%MS+1.81%0005.HK-0.07%HSBA.L+0.49%NZDCAD-1.55%NZDUSD-1.48%AUDNZD+1.36%GBPNZD+1.08%NZDCHF-1.02%CADJPY+0.85%EURNZD+0.83%USDJPY+0.77%NZDJPY-0.72%EURCAD-0.69%USDMXN+0.66%AUDJPY+0.65%EURUSD-0.64%CADCHF+0.53%EURAUD-0.51%GBPCAD-0.51%NZDMXN+0.49%USDCHF+0.46%EURSEK-0.44%GBPUSD-0.42%GBPTRY+0.41%AUDSGD-0.36%GBPJPY+0.34%AUDCHF+0.34%CHFJPY+0.33%CHFSEK-0.32%GBPHKD+0.32%GBPAUD-0.29%GBPMXN-0.28%USDTRY+0.28%USDNOK+0.26%EURCNH-0.24%USDSEK-0.24%EURGBP-0.21%AUDCAD-0.20%USDDKK+0.20%USDZAR+0.20%EURCHF-0.20%AUDDKK-0.19%EURHKD-0.19%CHFNOK+0.17%EURSGD-0.17%EURPLN-0.16%USDILS+0.16%EURJPY+0.14%AUDNOK-0.14%AUDUSD-0.13%USDCNH-0.12%NZDSGD-0.12%GBPZAR+0.12%NOKJPY-0.11%SGDJPY+0.11%PLNJPY+0.11%USDTHB-0.08%EURCZK-0.06%USDHKD+0.06%EURNOK+0.06%USDCAD-0.06%CHFSGD-0.05%GBPSGD-0.05%USDCOP-0.04%USDSGD+0.04%USDPLN+0.03%GBPCHF+0.02%EURZAR-0.01%EURDKK0.00%XPTUSD-3.38%GAGUSD-2.64%XAGUSD-2.64%XNGUSD-1.72%HG1-1.45%USOIL-1.23%COFFEE-1.16%SUGAR+1.08%XAUUSD-1.02%GAUUSD-1.02%UKOIL-0.71%COTTON+0.61%BTCUSD-1.49%ETHUSD+22.03%USDTUSD-0.03%XRPUSD+13.23%SOLUSD+15.69%TRXUSDT+0.68%ZECUSDT-2.40%DOGEUSD+17.55%XMRUSDT+0.59%LINKUSD+21.12%BCHUSDT-3.37%XLMUSD-0.61%UNIUSD+0.06%LTCUSD+13.00%SUIUSD-1.58%HBARUSDT-0.86%TONUSD+38.24%TAOUSDT-2.05%AAVEUSD-0.79%DOTUSDT-1.77%ICPUSDT-2.41%ONDOUSDT-1.51%WLDUSDT+1.93%ARBUSDT-0.53%JUPUSDT-3.37%INJUSDT+4.40%ATOMUSDT-1.13%STXUSDT-2.14%TIAUSDT-2.01%FETUSDT-1.55%PYTHUSDT-2.62%SEIUSDT-2.16%IMXUSDT-3.21%GRTUSDT-2.07%OPUSDT-2.29%WIFUSDT-2.27%IOTAUSDT+0.86%POLUSDT+0.20%AXSUSDT-2.48%EOSUSDT+1.14%FARTCOINUSDT+1.62%DYDXUSDT+0.51%GALAUSDT-1.78%ORDIUSDT+1.75%RONINUSDT+1.33%NOTUSDT+2.25%NVDA-0.30%AAPL+1.26%GOOGL+1.34%MSFT+2.65%AMZN-2.09%TSM+0.60%SPCX-2.25%AVGO+2.77%TSLA+0.18%META+1.30%LLY+0.54%SKHY+13.30%BRK-B-0.49%MU-1.89%WMT-0.46%AMD+3.24%JPM+1.05%XOM+1.17%V-0.31%JNJ+0.86%ASMLa+0.04%MA+0.08%ABBV-0.01%INTC+1.91%1398.HK+2.23%CVX+0.46%0700.HK-2.58%ORCL+10.58%COST-0.95%CSCO-0.98%KO+0.60%1816.HK+7.22%PG-0.61%UNH-0.80%BAC+0.34%3988.HK+1.66%AMAT+5.07%CAT+0.01%AP2d-0.42%0857.HK+2.91%LRCX+5.39%HD-0.30%PM+0.01%DELL-1.64%0939.HK+2.12%GE+1.17%1288.HK+1.48%MS+1.81%0005.HK-0.07%HSBA.L+0.49%NZDCAD-1.55%NZDUSD-1.48%AUDNZD+1.36%GBPNZD+1.08%NZDCHF-1.02%CADJPY+0.85%EURNZD+0.83%USDJPY+0.77%NZDJPY-0.72%EURCAD-0.69%USDMXN+0.66%AUDJPY+0.65%EURUSD-0.64%CADCHF+0.53%EURAUD-0.51%GBPCAD-0.51%NZDMXN+0.49%USDCHF+0.46%EURSEK-0.44%GBPUSD-0.42%GBPTRY+0.41%AUDSGD-0.36%GBPJPY+0.34%AUDCHF+0.34%CHFJPY+0.33%CHFSEK-0.32%GBPHKD+0.32%GBPAUD-0.29%GBPMXN-0.28%USDTRY+0.28%USDNOK+0.26%EURCNH-0.24%USDSEK-0.24%EURGBP-0.21%AUDCAD-0.20%USDDKK+0.20%USDZAR+0.20%EURCHF-0.20%AUDDKK-0.19%EURHKD-0.19%CHFNOK+0.17%EURSGD-0.17%EURPLN-0.16%USDILS+0.16%EURJPY+0.14%AUDNOK-0.14%AUDUSD-0.13%USDCNH-0.12%NZDSGD-0.12%GBPZAR+0.12%NOKJPY-0.11%SGDJPY+0.11%PLNJPY+0.11%USDTHB-0.08%EURCZK-0.06%USDHKD+0.06%EURNOK+0.06%USDCAD-0.06%CHFSGD-0.05%GBPSGD-0.05%USDCOP-0.04%USDSGD+0.04%USDPLN+0.03%GBPCHF+0.02%EURZAR-0.01%EURDKK0.00%XPTUSD-3.38%GAGUSD-2.64%XAGUSD-2.64%XNGUSD-1.72%HG1-1.45%USOIL-1.23%COFFEE-1.16%SUGAR+1.08%XAUUSD-1.02%GAUUSD-1.02%UKOIL-0.71%COTTON+0.61%BTCUSD-1.49%ETHUSD+22.03%USDTUSD-0.03%XRPUSD+13.23%SOLUSD+15.69%TRXUSDT+0.68%ZECUSDT-2.40%DOGEUSD+17.55%XMRUSDT+0.59%LINKUSD+21.12%BCHUSDT-3.37%XLMUSD-0.61%UNIUSD+0.06%LTCUSD+13.00%SUIUSD-1.58%HBARUSDT-0.86%TONUSD+38.24%TAOUSDT-2.05%AAVEUSD-0.79%DOTUSDT-1.77%ICPUSDT-2.41%ONDOUSDT-1.51%WLDUSDT+1.93%ARBUSDT-0.53%JUPUSDT-3.37%INJUSDT+4.40%ATOMUSDT-1.13%STXUSDT-2.14%TIAUSDT-2.01%FETUSDT-1.55%PYTHUSDT-2.62%SEIUSDT-2.16%IMXUSDT-3.21%GRTUSDT-2.07%OPUSDT-2.29%WIFUSDT-2.27%IOTAUSDT+0.86%POLUSDT+0.20%AXSUSDT-2.48%EOSUSDT+1.14%FARTCOINUSDT+1.62%DYDXUSDT+0.51%GALAUSDT-1.78%ORDIUSDT+1.75%RONINUSDT+1.33%NOTUSDT+2.25%

Beyond Meat rolls out steak filet at Sprouts

NEWS

October 29, 2026 at 10:34 UTC

3 min read
Unbranded plant-based steak-style strips on a plate at a Sprouts grocery store, tied to BYND product rollout

Key Points

  • 01Beyond Meat (BYND) launches Beyond Steak Filet nationwide at Sprouts stores
  • 02Product offers 28g plant protein, 3g fiber, and 1g saturated fat per serving
  • 03Beyond Steak Filet is Clean Label Project Certified and Non-GMO Project Verified
  • 04Sprouts’ more than 500 stores expand reach of a top-selling plant-based steak

Beyond Steak Filet launches nationwide at Sprouts

Beyond Meat (BYND) has launched its Beyond Steak Filet product nationwide at Sprouts Farmers Market stores, expanding the availability of its plant-based whole-cut steak. The announcement, made on October 29, 2026, marks a chainwide rollout across Sprouts locations in the United States.

The introduction of Beyond Steak Filet into Sprouts’ network brings the product to a retailer that operates more than 500 stores across 25 states and specializes in fresh, natural, and organic foods. This positions the product within a grocery environment focused on better-for-you offerings.

Product formulation and nutritional profile

Beyond Steak Filet is made with mycelium and avocado oil and is designed to deliver a tender, juicy, plant-based whole-cut steak experience. Each serving provides 28 grams of plant protein, 3 grams of fiber, and 1 gram of saturated fat.

The product uses faba bean protein and contains no added hormones or antibiotics. It is produced using non-GMO ingredients and delivers 0 milligrams of cholesterol per serving as part of Beyond Meat’s broader plant-based portfolio.

Beyond Steak Filet is Clean Label Project Certified and Non-GMO Project Verified, aligning it with Sprouts Farmers Market’s focus on better-for-you products. The certification and verification support the product’s positioning for consumers seeking simple and transparent ingredient lists.

Market performance and prior retail rollouts

Before entering Sprouts, Beyond Steak Filet had already been launched at Erewhon, Wegmans, H-E-B, and Meijer. The Sprouts rollout builds on this earlier distribution and brings the product to a wider national audience.

According to SPINS Total US Food Channel data for the 12 weeks through October 4, 2026, Beyond Steak Filet is among the best-selling new plant-based steak products.

Strategic fit with Sprouts and company positioning

Sprouts Farmers Market, based in Phoenix, employs approximately 36,000 team members and focuses on natural and organic products, making it a strategic channel for Beyond Steak Filet. The alignment between Sprouts’ assortment and Beyond Meat’s better-for-you positioning supports the product’s expansion.

Beyond Meat describes itself as Beyond The Plant Protein Company and offers a portfolio of plant-based protein products aimed at matching the taste and texture of animal-based meat. The company emphasizes non-GMO ingredients, no added hormones or antibiotics, and a focus on nutrition for its core offerings, including Beyond Steak Filet.

Ethan Brown, founder and CEO of Beyond Meat, said the company is pleased to bring Beyond Steak Filet to Sprouts Farmers Market and described the product as designed to deliver the taste of steak, a satisfying texture, and strong nutritional attributes. He characterized the launch as expanding access to a new kind of steak experience centered on taste, texture, and nutrition.

Key Takeaways

  • 01The nationwide Sprouts rollout significantly broadens distribution for Beyond Steak Filet within a retailer focused on natural and organic products.
  • 02Beyond Steak Filet’s nutritional profile and certifications position it squarely in the better-for-you segment of the plant-based meat market.
  • 03Early sales data indicating strong performance among new plant-based steak items suggest solid consumer traction for the product.
  • 04Alignment between Beyond Meat (BYND)’s non-GMO, no-hormone positioning and Sprouts’ assortment strategy supports further brand visibility and trial.